Dabrafenib Mesylate and Emicizumab-kxwh Subcutaneous
Determining the interaction of Dabrafenib Mesylate and Emicizumab-kxwh Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dabrafenib
Brand name: Tafinlar
Synonyms: Dabrafenib
Generic Name: emicizumab
Brand name: Hemlibra, Hemlibra 105 mg/07 mL, Hemlibra 60 mg/04 mL
Synonyms: Emicizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dabrafenib Mesylate-Emla
- Dabrafenib Mesylate-Emla Topical
- Dabrafenib Mesylate-Emo-Cort Scalp Solution Topical application
- Dabrafenib Mesylate-Emo-Cort Topical application
- Dabrafenib Mesylate-Emoquette
- Dabrafenib Mesylate-Empagliflozin
- Emicizumab-kxwh Subcutaneous-Dacarbazine
- Emicizumab-kxwh Subcutaneous-Dacarbazine Intravenous, Injection
- Emicizumab-kxwh Subcutaneous-Daclatasvir
- Emicizumab-kxwh Subcutaneous-Daclatasvir Dihydrochloride
- Emicizumab-kxwh Subcutaneous-Daclizumab
- Emicizumab-kxwh Subcutaneous-Daclizumab Subcutaneous